India to United States: Tamoxifen Export Trade Route
India has recorded 141 verified shipments of Tamoxifen exported to United States, representing a combined trade value of $5.1M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $36.2K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 100% of total export value with 140 shipments worth $5.1M USD. On the buying side, AUROBINDO PHARMA USA., INC, is the largest importer in United States with $2.4M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Tamoxifen corridor is one of India's established pharmaceutical export routes, with 141 shipments documented worth a combined $5.1M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's tamoxifen manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $36.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with tamoxifen's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #7 among India's top tamoxifen export destinations globally.
On the import side, key buyers of Indian tamoxifen in United States include AUROBINDO PHARMA USA., INC,, AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA.INC.,. and 8 others. AUROBINDO PHARMA USA., INC, is the single largest importer with 82 shipments valued at $2.4M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#7
- Annual growth+25.7%
- Demand growth+23.5%
- Regulatory ease86/100
Top 10 Indian Tamoxifen Exporters to United States
Showing top 10 of 2 Indian suppliers exporting Tamoxifen to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $36.4K per shipment | 140 | $5.1M | 99.9% |
| 2 | AUTIYUQ 1 WHOLE LIFE PRIVATE LIMITED Avg $4.7K per shipment | 1 | $4.7K | 0.1% |
This table shows the top 10 of 2 Indian companies exporting tamoxifen to United States, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, AUTIYUQ 1 WHOLE LIFE PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 140 shipments worth $5.1M USD, giving it a 100% market share.
Top 10 Tamoxifen Importers in United States
Showing top 10 of 11 known buyers in United States receiving Tamoxifen shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian tamoxifen in United States include AUROBINDO PHARMA USA., INC,, AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA.INC.,., AUROBINDO PHARMA USA., INC, AUROLOGISTICS LLC AUROBINDO PHARM, among 11 total buyers. The largest importer is AUROBINDO PHARMA USA., INC,, accounting for $2.4M USD across 82 shipments — representing 48% of all tamoxifen imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA USA., INC, | 82 | $2.4M | 47.8% |
| 2 | AUROBINDO PHARMA USA INC | 25 | $1.2M | 23.2% |
| 3 | AUROBINDO PHARMA USA.INC.,. | 4 | $400.9K | 7.9% |
| 4 | AUROBINDO PHARMA USA., INC | 8 | $351.2K | 6.9% |
| 5 | AUROLOGISTICS LLC AUROBINDO PHARM | 6 | $322.2K | 6.3% |
| 6 | AUROBINDO PHARMA USA. INC | 4 | $142.5K | 2.8% |
| 7 | AUROLOGISTICS LLC, (AUROBINDO PHARM | 7 | $119.1K | 2.3% |
| 8 | AUROLOGISTICS LLC, | 2 | $73.5K | 1.4% |
| 9 | AUROBINDO PHARMA USA INC NA | 1 | $37.5K | 0.7% |
| 10 | AUROLOGISTICS LLC (AUROBINDO PHARM | 1 | $33.2K | 0.7% |
Showing top 10 of 11 Tamoxifen importers in United States on this route.
Top 10 Tamoxifen Formulations Imported by United States
Showing top 10 of 94 product formulations shipped on the India to United States Tamoxifen route, ranked by trade value
United States imports a wide range of tamoxifen formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TAMOXIFEN TABLET 20MG ((Tamoxifen Citrate Tablets USP 20 mg) (140143X30'S) — accounts for $226.9K USD across 1 shipments. There are 94 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TAMOXIFEN TABLET 20MG ((Tamoxifen Citrate Tablets USP 20 mg) (140143X30'S) | 1 | $226.9K | 4.4% |
| 2 | TAMOXIFEN TABLET 20MG | 6 | $226.6K | 4.4% |
| 3 | TAMOXIFEN TABLET 20MG TAMOXIFEN CITRATETABLETS USP 20 MG - US 30 S COUNT QTY: 49581 PACKS | 2 | $145.7K | 2.9% |
| 4 | TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 110543 PACKS) | 1 | $142.2K | 2.8% |
| 5 | TAMOXIFEN TABLET 20MG 82172 X 30 S | 1 | $137.3K | 2.7% |
| 6 | TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATE | 2 | $125.3K | 2.5% |
| 7 | TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATE | 1 | $123.8K | 2.4% |
| 8 | TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 80480 PACKS) | 1 | $112.4K | 2.2% |
| 9 | TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 75975 PACKS) | 1 | $106.9K | 2.1% |
| 10 | TAMOXIFEN TABLET 20MG (54239X30'S) | 1 | $86.3K | 1.7% |
Showing top 10 of 94 Tamoxifen formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 72 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's tamoxifen exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 140 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, AUTIYUQ 1 WHOLE LIFE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $36.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as tamoxifen tablet 20mg and tamoxifen tablet 20mg tamoxifen citratetablets usp 20 mg - us 30 s count qty: 49581 packs, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, AUROBINDO PHARMA USA., INC, is the largest importer with 82 shipments worth $2.4M USD — representing 48% of all tamoxifen imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $5.1M
- Avg. Shipment
- $36.2K
- Suppliers
- 2
- Buyers
- 11
- Transit (Sea)
- ~17 days
- Annual Growth
- +25.7%
Reverse Direction
United States → India — Tamoxifen (Import)Other Tamoxifen Routes
Unlock the Full India to United States Tamoxifen Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 141 shipments on this route.
Frequently Asked Questions — India to United States Tamoxifen Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Tamoxifen to United States?
The leading Indian exporters of Tamoxifen to United States are EUGIA PHARMA SPECIALITIES LIMITED, AUTIYUQ 1 WHOLE LIFE PRIVATE LIMITED. EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Tamoxifen exports from India to United States?
India exports Tamoxifen to United States worth approximately $5.1M USD across 141 recorded shipments. The average value per shipment is $36.2K USD.
Q Which ports does India use to ship Tamoxifen to United States?
The most active port of origin is HYDERABAD AIR with 72 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Tamoxifen?
The average transit time for Tamoxifen shipments from India to United States is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Tamoxifen trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.7% with demand growth tracking at 23.5%. The route is ranked #7 among India's top Tamoxifen export destinations globally.
Q How many suppliers are active on the India to United States Tamoxifen route?
There are currently 2 active Indian suppliers exporting Tamoxifen to United States. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Tamoxifen from India in United States?
The leading importers of Indian Tamoxifen in United States include AUROBINDO PHARMA USA., INC,, AUROBINDO PHARMA USA INC, AUROBINDO PHARMA USA.INC.,., AUROBINDO PHARMA USA., INC, AUROLOGISTICS LLC AUROBINDO PHARM. AUROBINDO PHARMA USA., INC, is the largest buyer with 82 shipments worth $2.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Tamoxifen.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 11 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 141 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
141 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists